Skip to content

← All developments

New Mexico Office of Superintendent of Insurance · June 13, 2026 · Primary source

NOTICE OF PRESCRIPTION DRUG PRICE TRANSPARENCY ANNUAL MEETING

Score 46PRIMARYguidanceState insurance deptNM

Summary

New Mexico's Office of the Superintendent of Insurance has noticed a public meeting on June 12, 2026, to present findings and recommendations from its 2025 Prescription Drug Price Transparency legislative report. The meeting is virtual and open to public comment. The notice does not disclose substantive findings, recommendations, or any proposed regulatory action. This item is a duplicate of item 3 above.

What this may mean

Pharmaceutical manufacturers, PBMs, and health plans operating in New Mexico may wish to monitor the report's findings for potential future legislative or regulatory action. Procedural in nature; no direct operational compliance obligation arises from the meeting notice itself. Organizations with New Mexico market exposure could consider participating to assess the direction of state drug pricing policy.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items